Tirabrutinib

Name: Tirabrutinib in Primary central nervous system lymphoma: Natural history, survival, and mortality
Published: 2026-09-14T15:39:06-04:00

Primary central nervous system lymphoma

Section

Natural history, survival, and mortality

2 evidence topics · 2 sources

“the median overall survival in published trials generally ranges from 2 to 5 years.” (opens the source at this quote in a new tab)

“The 5-year survival rate for elderly patients was about 30% in the 2010s.” (opens the source at this quote in a new tab)